Both in Testing Laboratories
20/20 Biolabs vs NeoGenomics
Over the past year AIDX returned −99.0% and NEO returned +67.2%; their daily moves had a correlation of -0.86.
AIDX −99.0% NEO +67.2%Growth of $1, one year, split-adjusted
| Metric | AIDX | NEO |
|---|---|---|
| Price | $0.2290 | $16.74 |
| Market cap | $2.9M | $2.17B |
| Today | +7.51% | −3.68% |
| 1 month | −39.7% | −9.4% |
| 6 months | — | +86.0% |
| Year to date | — | +42.3% |
| 1 year | — | +72.8% |
| Revenue growth (YoY) | — | +11.4% |
| Gross margin | 41.7% | 46.2% |
| Net margin | −376.8% | −3.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.7× |
| Net cash | $4.5M | -$241.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 52.8% |
| Short % of float | 0.1% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).